Drugs / TURKOVAC-Dollvet
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05210179 Comparator | Jan 2022 → Feb 2023 | COVID-19 | Health Institutes of Turkey | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TURKOVAC-Dollvet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05210179 ↗ |
| Modality | Vaccine | “booster vaccination (TURKOVAC) against Covid-19” NCT05210179 ↗ |
| Route | Intramuscular | “administered by injection into the deltoid muscle” NCT05210179 ↗ |